$ADNT

Carlin Peter sold $151K of ADNT

Carlin Peter sold 7,843 shares of Adient plc (ADNT) at $19.25 ($0.15M total) on 2026-09-02.

Original reporting
SEC EDGAR · Carlin Peter
Published Sep 4, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 4, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ADNT
Bearish
medium confidence
Mentioned
$ADNT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ADNTBearishLow
01

Why it matters

The director's sale may be interpreted as a lack of confidence, but the amount is relatively small.

02

Market read

Minor insider sale; limited impact on broader market.

03

Timing

Filed Sep 4 2026

Relevance 4/10Novelty 4/10Timing: Filed Sep 4 2026

Background

SEC Form 4 filing discloses insider transactions.

Company-level read

Ticker impact

$ADNTBearishMedium confidence
Context

Director Carlin Peter sold 7,843 shares of ADNT for $150,978 on Sep 2, 2026.

Expected impact

Potential slight downward pressure on ADNT price.

Evidence & confidence

The sale size is modest ($151K) but involves a director, which can influence short-term sentiment.

Key entities

  • Adient plc

    Automotive seating manufacturer listed on NYSE (ADNT).

  • Carlin Peter

    Director of Adient plc.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ADNTMed

Adient misses earnings estimates despite stronger-than-expected revenue

Adient (NYSE:ADNT) reported Q3 adjusted EPS of $0.48, below the $0.57 consensus, while revenue rose to $3.93B versus a $3.7B forecast. The company cited about $32M in temporary headwinds and operational inefficiencies. Adient kept FY2026 guidance, expecting ~$15B revenue, and reported GAAP net income of $25M. Shares were down ~0.9% premarket.

$ADNTMedAI 8/10

Adient reports third quarter financial results; reaffirms earnings and FCF outlook for FY26

Adient (NYSE: ADNT) reported Q3 2026 results: GAAP net income of $25M and diluted EPS of $0.32, versus adjusted diluted EPS of $0.48. Adjusted EBITDA was $225M, roughly flat year over year despite about $32M of temporary headwinds. At June 30, 2026, gross debt was ~$2.4B, net debt ~$1.5B, and cash ~$924M. The company said it generated free cash flow and repurchased $30M of shares in Q3.

$ADNTMed

Adient plc (ADNT): Results of Operations and Financial Condition

Adient plc (ADNT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Appendix Page 1 Adient plc Condensed Consolidated Statements of Income (Loss) (Unaudited) Three Months Ended June 30, (in millions, except per share data) 2026 2025 Net sales $ 3,929 $ 3,741 Cost of sales 3,694 3,504 Gross profit 235 237 Selling, general and administ

$ADNTLow

Adient plc (ADNT) Releases China Business Update

Adient plc (NYSE:ADNT) said in a May 20 China business update that since last year’s J.P. Morgan Summit it has received new bookings supporting sales growth. The company reported about $1.1 billion in annual business in FY2025 from four new auto brands, with ~70% from C-OEMs. It also noted a December 2025 JV via a 49% stake in SCI (Zhangjiakou) Co., Ltd.